Get the Stockscreener App
0.87
2.20%
-0.0196
Atossa Therapeutics Inc stock is traded at $0.87, with a volume of 410.30K.
It is down -2.20% in the last 24 hours and down -13.86% over the past month.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
See More
Previous Close:
$0.8896
Open:
$0.9
24h Volume:
410.30K
Relative Volume:
0.49
Market Cap:
$111.85M
Revenue:
-
Net Income/Loss:
$-26.91M
P/E Ratio:
-3.9545
EPS:
-0.22
Net Cash Flow:
$-19.57M
1W Performance:
-7.76%
1M Performance:
-13.86%
6M Performance:
+1.71%
1Y Performance:
-38.73%
1-Day Range:
$0.8534
$0.907
1-Week Range:
$0.8534
$0.9579
52-Week Range:
$0.5526
$1.66
Atossa Therapeutics Inc Stock (ATOS) Company Profile
Name
Atossa Therapeutics Inc
Sector
Industry
Phone
206.588.0256
Address
10202 5TH AVENUE NE, SEATTLE, WA
Compare ATOS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ATOS
Atossa Therapeutics Inc
|
0.8659 | 114.91M | 0 | -26.91M | -19.57M | -0.22 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.83 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
641.76 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.40 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
821.96 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.94 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Atossa Therapeutics Inc Stock (ATOS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-26-18 | Initiated | Maxim Group | Buy |
Atossa Therapeutics Inc Stock (ATOS) Latest News
Is a relief rally coming for Atossa Therapeutics Inc. holdersMarket Performance Recap & Real-Time Volume Surge Alerts - newser.com
What momentum indicators show for Atossa Therapeutics Inc. stockShare Buyback & Consistent Growth Equity Picks - newser.com
Will Atossa Therapeutics Inc. (YAG2) stock announce a stock split2025 Volatility Report & Long-Term Growth Stock Strategies - newser.com
How rising interest rates impact Atossa Therapeutics Inc. stockWeekly Trade Recap & Consistent Income Trade Recommendations - newser.com
Is Atossa Therapeutics Inc. reversing from oversold territoryLong Setup & Entry Point Confirmation Signals - newser.com
Will Atossa Therapeutics Inc. stock benefit from commodity pricesPortfolio Value Summary & Short-Term Swing Trade Alerts - newser.com
Published on: 2025-11-03 03:32:49 - newser.com
Does Atossa Therapeutics Inc. fit your quant trading modelMarket Performance Summary & Long-Term Capital Growth Strategies - newser.com
Atossa Therapeutics Inc. stock trend outlook and recovery pathMarket Activity Recap & Scalable Portfolio Growth Ideas - newser.com
What earnings revisions data tells us about Atossa Therapeutics Inc.Analyst Downgrade & Community Verified Watchlist Alerts - newser.com
Why Atossa Therapeutics Inc. stock is seen as undervaluedEarnings Miss & Free Reliable Trade Execution Plans - newser.com
Candlestick signals on Atossa Therapeutics Inc. stock todayEarnings Miss & Low Drawdown Momentum Trade Ideas - newser.com
How Atossa Therapeutics Inc. stock trades before earningsJuly 2025 Setups & High Conviction Investment Ideas - newser.com
How cyclical is Atossa Therapeutics Inc. (YAG2) stock compared to rivalsJuly 2025 Volume & Fast Gain Swing Trade Alerts - newser.com
How Atossa Therapeutics Inc. (YAG2) stock trades after earningsDividend Hike & Accurate Entry/Exit Alerts - newser.com
Is Atossa Therapeutics Inc. stock a smart buy before Fed meetingGlobal Markets & AI Forecast for Swing Trade Picks - newser.com
Is Atossa Therapeutics Inc. stock attractive for income investors2025 Trade Ideas & Verified Short-Term Plans - newser.com
Will Atossa Therapeutics Inc. stock split again soonWeekly Profit Recap & Pattern Based Trade Signal System - newser.com
What moving averages say about Atossa Therapeutics Inc.July 2025 Summary & Stock Timing and Entry Methods - newser.com
Can Atossa Therapeutics Inc. stock sustain market leadershipQuarterly Trade Summary & Fast Entry Momentum Trade Alerts - newser.com
Will Atossa Therapeutics Inc. (YAG2) stock hit analyst forecastsPortfolio Return Report & Weekly Market Pulse Updates - newser.com
Visual analytics tools that track Atossa Therapeutics Inc. performance2025 EndofYear Setup & Free High Return Stock Watch Alerts - newser.com
Atossa Genetics (NASDAQ:ATOS) Share Price Passes Above 200 Day Moving AverageShould You Sell? - MarketBeat
Atossa Genetics Inc. (NASDAQ:ATOS) Sees Large Drop in Short Interest - MarketBeat
Applying big data sentiment scoring on Atossa Therapeutics Inc.Portfolio Update Summary & Low Drawdown Trading Strategies - newser.com
Can Atossa Therapeutics Inc. (YAG2) stock reach $200 price target2025 Market Sentiment & Reliable Intraday Trade Alerts - newser.com
Is Atossa Therapeutics Inc. (YAG2) stock inflation resilientJuly 2025 Snapshot & AI Enhanced Market Trend Forecasts - newser.com
NioCorp and Atossa Therapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Amarillo Globe-News
Published on: 2025-10-31 05:58:12 - newser.com
What hedge fund moves indicate for Atossa Therapeutics Inc. (YAG2) stockLong Setup & Risk Adjusted Swing Trade Ideas - newser.com
When is the best time to exit Atossa Therapeutics Inc.2025 Performance Recap & Weekly High Momentum Picks - newser.com
Atossa Therapeutics Inc. stock outlook for YEARJuly 2025 Retail & Risk Adjusted Swing Trade Ideas - newser.com
Detecting price anomalies in Atossa Therapeutics Inc. with AIOptions Play & Verified Momentum Stock Watchlist - newser.com
How high can Atossa Therapeutics Inc. stock goCPI Data & Safe Capital Growth Tips - newser.com
Atossa Therapeutics Inc Stock (ATOS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.29%
0.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):